Clinical Trial Update: A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating dupilumab for inducing clinical remission in asthma. The study is currently recruiting and sponsored by Université de She…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Asthma Control | Phase 3 | Status: RECRUITING